Skip to search formSkip to main contentSkip to account menu

Luminal A Breast Carcinoma

Known as: Luminal A Estrogen Receptor Positive Subtype of Breast Carcinoma, Luminal A Subtype of Breast Carcinoma, Luminal A Breast Cancer 
A biologic subset of breast carcinoma defined by high expression of genes characteristic of luminal epithelial cells, including estrogen receptor (ER… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background: In luminal early breast cancer (EBC) with limited nodal involvement, current guidelines recommend to use multigene… 
2016
2016
Background: Young women present more often with aggressive breast cancer phenotypes and have worse prognosis. It remains… 
2015
2015
ZusammenfassungHintergrundNeben Brustkrebsrisikofaktoren wie Hormoneinfluss, Reproduktionsverhalten und Lifestylefaktoren führen… 
2015
2015
Background: HR-positive BC heterogeneously sensitive to neoadjuvant chemotherapy (NEC), with pCR rates varying from 2 to 20% at… 
2013
2013
Background: Breast Cancer (BC) is molecularly diverse disease that has been sub-classified in four major subtypes; (a) luminal A… 
2013
2013
Background: Combined use of MammaPrint and a molecular subtyping profile (BluePrint) identifies disease subgroups with marked… 
2012
2012
Background: Luminal A (LumA) tumors are the most common subtype of breast cancer and have been associated with favorable… 
2012
2012
Background: Stratification of molecular subtypes is of outmost importance for clinical decision making according to the 12th St… 
2008
2008
11008 Background: The biological subtypes of breast cancer designated as Luminal A (LumA), Luminal B (LumB), HER2, and Basal have… 
2008
2008
510 Background: Gene expression profiling studies have consistently revealed prognostically significant breast cancer subtypes…